Sheila Gujrathi Insider Trading $FPRX FIVE PRIME THERAPEUTICS, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Sheila Gujrathi.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Sheila Gujrathi. Sheila Gujrathi is Director in FIVE PRIME THERAPEUTICS INC ($FPRX) and Chief Medical Officer in Receptos, Inc. ($RCPT) and Director in Turning Point Therapeutics, Inc. ($TPTX) and President & CEO in Gossamer Bio, Inc. ($GOSS).

Sheila Gujrathi in FIVE PRIME THERAPEUTICS, INC.

Trading Symbol: FPRX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Sheila Gujrathi: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 14 2018
$FPRX Market Capitalization: $1.23B
$FPRX Previous Close: $45.38

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Sheila Gujrathi in FIVE PRIME THERAPEUTICS, INC.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, FPRX, GOSS, RCPT, TPTX

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares
May 14 2018	FPRX	FIVE PRIME THERAPE ...	Gujrathi Sheila	Director	Option Exercise	A	17.27	10,000	172,700	10,000
May 12 2017	FPRX	FIVE PRIME THERAPE ...	Gujrathi Sheila	Director	Option Exercise	A	29.80	10,000	298,000	10,000
May 23 2016	FPRX	FIVE PRIME THERAPE ...	Gujrathi Sheila	Director	Option Exercise	A	42.25	10,000	422,500	0
Dec 03 2015	FPRX	FIVE PRIME THERAPE ...	Gujrathi Sheila	Director	Option Exercise	A	37.99	25,000	949,750	25,000

Page: 1